1. SO-008Ramucirumab plus merestinib in previously treated metastatic colorectal cancer: safety, pharmacokinetic, and preliminary efficacy findings from a Phase 1 study. (2nd July 2019) Authors: Saleh, M; Cassier, P; Eberst, L; Naik, G; II, V Morris; Pant, S; Terret, C; Gao, L; Long, A; Mao, H; McNeely, S; Carlesi, R; Fu, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗